BP000258-CYT-284: Recombinant Rat Vascular Endothelial Growth Factor C (VEGF-C) Protein
Source: Sf9, Insect Cells-derived.
Measured by its ability to stimulate phosphorylation of the VEGFR-3/FLT-4 receptor in porcine aortic endothelial cells (PAE/FLT -4 cells). The ED50 for this effect is typically 150-300 ug/ml, corresponding to a specific activity of 3.3-6.6 KUnits/mg.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000258-CYT-262: Recombinant Rat Vascular Endothelial Growth Factor C (VEGF-C) Protein
Source: Sf9, Insect Cells-derived.
Measured by its ability to stimulate phosphorylation of the VEGFR-3/FLT-4 receptor in porcine aortic endothelial cells. The ED50 for this effect is typically 200-300 ug/ml corresponding to a Specific Activity of 3,334-5,000 IU/mg.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000258-CYT-527: Recombinant Human Vascular Endothelial Growth Factor C (VEGF-C) Protein
Source: Sf9, Insect Cells-derived.
Measured by its ability to bind to the VEGFR-3/FLT-4 receptor in the Ba/F3-hVEGFR-3 assay. The ED50 in this assay is about 4 ug/ml corresponding to a Specific Activity of 250,000 IU/mg.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000027-CYT-241: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein
Source: E. coli-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1-8 ug/ml corresponding to a Specific Activity of 125,000-1,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000027-CYT-226: Recombinant Mouse Vascular Endothelial Growth Factor (VEGF) Protein, Sf9
Source: Baculovirus Sf9 cells-derived.
The ED50 range, determined by the dose-dependent proliferation of human umbilical vein endothelial cells (HUVEC) (measured by 3H-thymidine uptake) is 1-2 ug/ml, corresponding to a specific activity of 1x106 Units/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000027-CYT-225: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein, HEK
Source: HEK 293 (Human Embryonic Kidney cell line)-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1-6 ug/ml corresponding to a Specific Activity of 166,667-1,000,000 IU/mg.
Purity: > 95% by SDS-PAGE.BP000027-CYT-200: Recombinant Human VEGF (121 a.a.) Protein, Sf9
Source: Sf9, Insect Cells-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 2-5 ug/ml corresponding to a Specific Activity of 200,000-500,000 IU/mg.
Purity: >90% by SDS-PAGE and RP-HPLC.BP000119-CYT-462: Recombinant Human Thrombopoietin, CHO
Source: Chinese Hamster Ovarian Cells (CHO)-derived.
The ED50 as determined by the dose-dependant stimulation of MO7e cells is 1-3 ug/ml, corresponding to a Specific Activity of 1 x 106 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000119-CYT-115: Recombinant Human Thrombopoietin, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) and is typically 0.5-5 ug/ml.
Purity > 90%, by SDS-PAGE.BP000119-CYT-346: Recombinant Mouse Thrombopoietin
Source: E. coli-derived.
ED50 range is less than 1 ug/ml as determined by the dose dependent proliferation of Mo7e cells.
Purity > 95%, by SDS-PAGE.